The role of the healthcare regulator in the grant of patents for medicines | Practical Law
The role of the Brazilian Sanitary Surveillance Agency (ANVISA) in granting patents for pharmaceutical products and processes is still unclear. This article examines the reasons for the ANVISA prior consent rule, interpreting the prior consent rule, balancing the rights to healthcare and to IP rights, and the current position in practice.